10.23.20

Moderna Hits 30,000 Enrollment Target in Phase 3 Coronavirus Vaccine Trial

Source: FirstWord

10.22.20

Suspected Control Group Participant in AstraZeneca COVID-19 Vaccine Study Dies; Trial Continues

Source: FirstWord

10.21.20

Sources Say US Study of AstraZeneca’s COVID-19 Vaccine May Restart This Week

Source: FirstWord

10.20.20

Volunteers to be Infected With Coronavirus in World’s First ‘Human Challenge’ Trials

Source: Financial Times

10.19.20

Pfizer CEO Says Late November is Earliest Possible Filing Date for COVID-19 Vaccine in US

Source: FirstWord

10.19.20

CVS, Walgreens Make Deal With Trump Admin to Quickly Distribute COVID-19 Vaccines to Nursing Homes

Source: FierceHealthcare

10.13.20

Will Kids Get A COVID-19 Vaccine? Pfizer To Expand Trial To Ages 12 And Up

Source: NPR

10.13.20

J&J Pauses COVID-19 Vaccine Studies After “Unexplained Illness”

Source: FirstWord

10.08.20

Azar Lays Out Optimistic COVID-19 Vaccine Timeline of 100 Million Doses by End of 2020

Source: FierceHealthcare

10.07.20

FDA Releases EUA Guidelines That May Extend Review Time for COVID-19 Vaccines

Source: FirstWord

View more stories